Today: 20 March 2026
Browse Category

IPO Updates 13 October 2025 - 5 December 2025

Reliance Industries Share Price Today (5 December 2025): S&P Upgrade to ‘A-’, Jio IPO Buzz and 2026 Targets Keep RIL in Focus

Reliance Industries Share Price Today (5 December 2025): S&P Upgrade to ‘A-’, Jio IPO Buzz and 2026 Targets Keep RIL in Focus

S&P Global Ratings upgraded Reliance Industries’ long-term credit rating to ‘A-’ with a stable outlook on 5 December. Reliance shares traded at ₹1,524.20 on the NSE, down 0.92% intraday, near the upper end of their 52-week range. Work has started on a draft prospectus for a Jio Platforms IPO, which could become India’s largest listing. Reliance also acquired a 49% stake in Oval Invincibles, to be renamed “MI London” in 2026.
Meesho, Aequs & Vidya Wires IPOs on Final Day (Dec 5, 2025): GMP Today, Subscription Status, Listing Gain Hopes & Should You Apply?

Meesho, Aequs & Vidya Wires IPOs on Final Day (Dec 5, 2025): GMP Today, Subscription Status, Listing Gain Hopes & Should You Apply?

Meesho, Aequs, and Vidya Wires IPOs close for bidding in India today, December 5, 2025. Meesho is over 8 times subscribed with a grey market premium of ₹44–50, Aequs is 11 times subscribed with a GMP of ₹41–44, and Vidya Wires is about 9 times subscribed with a GMP of ₹5.5. Allotment is expected December 8; listing set for December 10.
5 December 2025
JD.com Stock Today, November 24, 2025: $500 Million JingDong Industrials IPO Plan Puts AI Supply-Chain Bet in Focus

JD.com Stock Today, November 24, 2025: $500 Million JingDong Industrials IPO Plan Puts AI Supply-Chain Bet in Focus

JD.com’s supply-chain tech unit, JingDong Industrials, is planning a Hong Kong IPO of up to $500 million, with investor meetings underway and a potential listing in early December. JD.com shares rose 0.5% to $29.08 in New York but remain near 52-week lows, leaving the company valued at about $41–42 billion. Hong Kong shares are still down roughly 18% for the year.
Capillary Technologies IPO Day 2 (Nov 17): Subscription builds to ~48% by late afternoon; GMP hovers at 4–5% — Should you apply?

Capillary Technologies IPO Day 2 (Nov 17): Subscription builds to ~48% by late afternoon; GMP hovers at 4–5% — Should you apply?

Capillary Technologies India’s ₹877.5-crore IPO was subscribed about 48% by 4:00 pm IST Monday, up from 38% at noon. The grey-market premium held at ₹23–₹25, or roughly 4–5% above the upper price band. Retail bids reached 0.89 times quota, non-institutional 0.44, and QIBs 0.29. The IPO runs through November 18.
17 November 2025
Groww IPO Day 2: Fully Subscribed (1.47x); Retail 4.65x, GMP 11–15%; Nithin Kamath Says 20% of Applications Came via Zerodha — What Top Brokerages Recommend

Groww IPO Day 2: Fully Subscribed (1.47x); Retail 4.65x, GMP 11–15%; Nithin Kamath Says 20% of Applications Came via Zerodha — What Top Brokerages Recommend

Groww’s ₹6,632.3-crore IPO was fully subscribed on Day 2, reaching 1.47 times overall bids by mid-afternoon, led by retail investors at 4.65 times. The grey market premium eased to around 11–15% above issue price. Zerodha’s Nithin Kamath said about 20% of Groww IPO applications came from Zerodha customers. The IPO closes November 7, with listing expected November 12.
6 November 2025
Tata Capital’s ₹15,500-Crore IPO Rocks 2025 Markets – Should You Bet on India’s Biggest Listing?

Tata Capital IPO Debut: Flat Start, But Analysts Say Hold On

Tata Capital’s ₹15,511.87 crore IPO, India’s largest of 2025, opened Oct 6–8 and listed Oct 13 at ₹330, about 1.2% above issue price. Shares saw muted grey-market premium and closed near debut price after brief gains. The IPO was 1.95× subscribed, with ₹4,642 crore raised from 135 anchor investors. Tata Sons sold 23 crore shares, and the IFC 3.58 crore, as part of a regulatory listing mandate.
13 October 2025

Stock Market Today

  • RTX Shares See 52% Gain in Year - Is It Overvalued at $200?
    March 20, 2026, 1:45 AM EDT. RTX's share price rose 51.8% over the past year but dropped 1.4% last month, trading around $200.73. A Discounted Cash Flow (DCF) analysis values RTX at $183.11, suggesting the stock is about 9.6% overvalued based on projected free cash flows. Despite promising aerospace and defense sector positioning, valuation signals are mixed, with a 3 out of 6 score indicating both undervaluation and fair pricing factors. Investors should watch RTX closely for market shifts and updates to fundamentals that could affect its value.
Go toTop